Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


European Commission Makes Final Decision On Cranberry Products

Executive Summary

Several manufacturers in the EU have marketed cranberry capsules as medical devices to gain regulatory and marketing advantages. Others have lobbied against this "unfair practice." France took the matter to the European Commission, which took action – the first time the commission employed its "borderline"-product designation authority.

You may also be interested in...

EU Regulatory Watershed Sees Widely Diverging Expert Views Over MDR As They Bid Farewell To Directives

Today marks the end of an era. Directives that have defined our working days for decades will now recede into history. Some have spoken of their nostalgia, some of optimism, and others of concerns. For one regulatory veteran, meanwhile, EU medtech is heading in the wrong direction.

Latest EU Borderline Manual: Recommended Reading For Rugby Players?

The EU's medical device borderline and classification manual has just been updated for the second time this year. It contains seven new entries, including a few surprising ones.

A Device Or Not A Device? 12 New Entries To EU Borderline Manual

The EU's manual on borderline products, where there is some ambiguity about whether medical device/IVD oversight applies, is set to be updated in line with the new Medical Devices and IVD Regulations. But in advance of that, the EU manual has been updated to provide guidance on 12 additional product types under the still-active Directive rules.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts